Robert Palmason, MD^1,2,3*, Sara Ekberg, PhD^4*, Elias Eythorsson, MD, PhD^1,2*, Sæmundur Rögnvaldsson, MD, PhD^1,2*, Sigrun Thorsteinsdottir, MD, PhD^1,5, Michael Crowther, PhD^4*, Elin Ruth Reed^1*, Jon Oskarsson, MSc^1*, Gudrun Asta Sigurdardottir^1*, Thor Aspelund, PhD^1*, Brynjar Vidarsson, MD^2*, Pall T. Onundarson, MD^1,2, Bjarni Agnarsson, MD^2*, Margret Sigurdardottir, MD^2*, Ingunn Thorsteinsdottir, MD, PhD^2*, Signy Vala Sveinsdottir, MD, PhD^2*, Isleifur Olafsson, MD, PhD^2*, Asdis Rosa Thordardottir^1*, Asbjorn Jonsson, MD^6*, Olafur Indridason, MD, MHS^2*, Gauti Gislason, MSc^1*, Andri Olafsson^1*, Jon Kristinn Sigurdsson^1*, Hlif Steingrimsdottir, MD^2*, Thorir E. Long, MD, PhD^1,3*, Malin Hultcrantz, MD, PhD⁷, Brian GM Durie, MD⁸, Stephen J. Harding, PhD⁹, Ola Landgren, MD¹⁰, Runolfur Palsson, MD^1,2*, Thorvardur Jon Love, MD, PhD^1* and Sigurdur Y. Kristinsson, MD, PhD^1,2

¹Faculty of Medicine, University of Iceland, Reykjavik, Iceland
²Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland
³Skane University Hospital, Lund, Sweden
⁴Red Door Analytics AB, Stockholm, Sweden
⁵Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
⁶Akureyri Hospital, Akureyri, Iceland
⁷Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
⁹The Binding Site Inc., Birmingham, United Kingdom
¹⁰Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL

Kara I. Cicero, MD, MPH¹, Xolisile Dlamini, MPH, BSN^2*, Yvonne Mavengere, MPH, HBMLS^3*, Jessica Justman, MD^4*, Harriet Nuwagaba-Biribonwoha, MD, PhD^3*, Mxolisi Dlamini, BSc^3*, Simphiwe Ngwenyama, MPH^3*, Cebisile Ngcamphalala, PhD^3*, Andrea Low, MD, PhD^4*, Neena M. Philip, PhD, MPH^4*, Wafaa M. El-Sadr, MD, MPH, MPA^4*, Ruben Sahabo, MD^3*, Tesfay Abreha, DVM, MSc, MPH^3*, Sintayehu Temesgen, MD, MMed^5*, Sindisiwe Dlamini, MPH, BSc, NHD^6*, Nokuthula Mahlalela, MPH^5*, Codruta Chiuzan, PhD^7*, Yuxuan Chen, MS^8*, Samuel S. Pan, MSc^9*, Suzanne Lentzsch, MD, PhD^1* and Alfred I. Neugut, MD, PhD^1*

¹Columbia University Irving Medical Center, New York Presbyterian, New York, NY
²National Cancer Prevention & Control, Eswatini Ministry of Health, Mbabane, Swaziland
³ICAP, Columbia University, Mbabane, Swaziland
⁴ICAP, Columbia University, New York, NY
⁵Eswatini Ministry of Health, Mbabane, Swaziland
⁶Eswatini Ministry of Health, Health Laboratory Services, Mbabane, Swaziland
⁷Feinstein Institutes for Medical Research, Northwell Health, New York, NY
⁸Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
⁹Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

George Mellgard^1*, Molly Gilligan^1*, Edward R Scheffer Cliff, MBBS, MPH², Divaya Bhutani, MD³, Ghulam Rehman Mohyuddin, MD⁴, Andrew Eisenberger, MD³, Suzanne Lentzsch, MD, PhD⁵ and Rajshekhar Chakraborty^1*

¹Columbia University Irving Medical Center, New York, NY
²Austin Health, Brooklyn, MA
³Columbia University Medical Center, New York, NY
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Division of Hematology & Oncology, Columbia University Medical Center, New York, NY

Carlos Bravo-Perez, MD^1,2*, Carmelo Gurnari, MD^1,3, Naomi Kawashima, MD, PhD^1*, Danai Dima, MD¹, Olisaemeka Ogbue¹, Luca Guarnera, MD^1*, Yasuo Kubota, MD, PhD^1*, Nakisha D Williams, MBBS^1*, Arooj Ahmed, MD^1*, Fauzia Ullah, MD^1*, Arda Durmaz^1*, Megan Nakashima, MD⁴, Valeria Visconte, PhD¹ and Jaroslaw P. Maciejewski, M.D., Ph.D., FACP¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
³Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
⁴Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH

Dickran Kazandjian, MD¹, Christin DeStefano, MD², Alexander Dew, DO, MS^3*, Elizabeth Hill, MD^4*, Katie Thoren^5* and Ola Landgren, MD⁶

¹Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Walter Reed National Military Medical Center, Chevy Chase, MD
³Walter Reed National Military Medical Center, Bethesda, MD
⁴National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵University of Miami, Miami, FL
⁶Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL

Urvi A Shah, MD¹, Francesca Castro, MS^2*, Andriy Derkach, PhD^3*, Teng Fei, PhD^4*, Kinga K Hosszu, PhD^5*, Devin McAvoy, BS^5*, Susan DeWolf, MD⁶, Justin Cross, PhD^7*, Ana Gradissimo, PhD^2*, Alexis Nwankwo^8*, Aishwarya Anuraj^8*, Miranda Burge^2*, Blaslov Jenna^8*, Elizabeth Raynor^8*, Jenna Wosleger^8*, Peter Adintori^2*, Michael Pollak, MD^9*, Jenny Paredes Sanchez, PhD², Thomas Atkinson, PhD^10*, Kylee H Maclachlan, MBChB, PhD¹, Sham Mailankody, MBBS¹, Neha Korde, MD¹, Carlyn Tan, MD¹, Malin Hultcrantz, MD, PhD¹, Hani Hassoun, MD¹, Jonathan U. Peled, MD, PhD¹¹, Gunjan L. Shah², Michael Scordo¹², Oscar Boutros Lahoud¹³, David Chung, MD, PhD¹², Heather Landau, MD¹³, Anita D'Souza, MD, MS¹⁴, Ola Landgren, MD¹⁵, Sergio A. Giralt, MD, FACP¹⁶, Neil M. Iyengar, MD, BS, BA^17*, Saad Z Usmani, MD^12,18, Alexander Lesokhin, MD¹ and Marcel R.M. van den Brink¹⁹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Memorial Sloan Kettering, New York, NY
⁸Memorial Sloan Kettering Cancer Center, New York
⁹McGill University, Montreal, QC, CAN
¹⁰Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York
¹¹Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Medical College of Wisconsin, Wisconsin
¹⁵Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
¹⁶Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Memorial Sloan-Ketter Cancer Ctr/NY Presb Hosp (Cornell), New York, NY
¹⁸Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁹Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY

Nikhil Grandhi, MD^1*, Lawrence Liu, MD^2*, Mei Wang^3*, Theodore Thomas, MD^3*, Akhil Kumar^4*, Feng Gao, MD, PhD^5*, Kristen M. Sanfilippo, MD⁶, Graham Colditz, MD, DrPh^7* and Su-Hsin Chang, PhD^3*

¹Washington University School of Medicine, Saint Louis, MO
²City of Hope National Medical Center, Duarte, CA
³St. Louis Veterans Affairs Medical Center Research Service, St. Louis, MO
⁴Research Service, St. Louis Veterans Affairs Medical Center, Saint Louis
⁵Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁶Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
⁷Washington University School of Medicine, Saint Louis

Lawrence Liu, MD^1,2*, Niharika Pant, MBBS^1*, Mei Wang^3*, Nikhil Grandhi, MD^4*, Ekaterina Proskuriakova, MD⁵, Murali Janakiram, MD, MS⁶, Theodore Thomas, MD^3*, Kristen M. Sanfilippo, MD⁷, Graham Colditz, MD, DrPh^8*, Daphne R Friedman, MD^9,10,11, Martin William Schoen, MD, MPH^12* and Su-Hsin Chang, PhD^3*

¹St. Louis Veterans Affairs Medical Center, St. Louis, MO
²City of Hope National Medical Center, Duarte, CA
³St. Louis Veterans Affairs Medical Center Research Service, St. Louis, MO
⁴Washington University School of Medicine, Saint Louis, MO
⁵Mount Sinai Hospital, Chicago, IL
⁶Division of Myeloma, Department of Hematology, City of Hope National Medical Center, Duarte, CA
⁷Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
⁸Washington University School of Medicine, Saint Louis
⁹Division of Medical Oncology, Duke University School of Medicine, Durham, NC
¹⁰Durham VA Medical Center, Durham, NC
¹¹National Oncology Program, Department of Veterans Affairs, Washington, DC
¹²Department of Veterans Affairs, St. Louis University, Saint Louis, MO

Sabrina L. Browning, MD¹, Allison J. Li, MD, PhD^2*, Terri L. Parker, MD¹, Noffar Bar, MD³, Tara Anderson, PA-C^4*, Erica Stevens, DNP, APRN, FNP-BC^4*, Yuxin Liu, MD¹, Martin Matthews, MS^1*, Jennifer VanOudenhove, PhD¹, Rebecca Cardone, MSc^5*, Qiushi Sun, PhD, MS^5*, Robert Hale, PhD^5*, Stephanie Halene, MD¹, Richard Kibbey, MD, PhD^6* and Natalia Neparidze, MD¹

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
³Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Cheshire, CT
⁴Yale-New Haven Hospital and Yale Cancer Center, New Haven, CT
⁵Department of Internal Medicine, Section of Endocrinology, Yale University School of Medicine, New Haven, CT
⁶Department of Internal Medicine, Section of Endocrinology and Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT

Catherine R. Marinac, PhD¹, Katelyn Downy^2*, Irene M. Ghobrial, MD^1,3, Jacqueline Perry, MPH^1*, Brittany Fischer-Longden, MPH^2*, Timothy R Rebbeck, PhD^2*, Elizabeth K. O'Donnell, MD¹, Omar Nadeem, MD^1,4 and Brian Egleston, PhD^5*

¹Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston
³The Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA
⁵Fox Chase Cancer Center, Philadelphia

Yawara Kawano, MD, PhD¹, Takeshi Masuda^2*, Shiho Fujiwara, MD^3*, Junzhe Bai^4*, Nao Nishimura, MD^5*, Hiroto Ohguchi, MD/PhD^6* and Jun-ichirou Yasunaga, MD, PhD⁴

¹Dept of Hematology, Kumamoto University Hospital, Kumamoto, Japan
²Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan
³Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan
⁴Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan
⁵Kumamoto University Hospital, Kumamoto, Japan
⁶Division of Disease Epigenetics, IRDA, Kumamoto University, Kumamoto, Japan

Dor Shpitzer, BSc^1*, Yael C. Cohen^2,3*, Chava Perry, MD^3,4*, Anat Reiner-Benaim, PhD^5* and Irit Avivi Mazza, MD^3,4,6*

¹Ben Gurion University of the Negev, Tel Aviv, NY, Israel
²Tel -Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Department of Epidemiology, Biostatistics and Community Health Sciences School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
⁶Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Niharika Pant, MBBS^1*, Lawrence Liu, MD^2,3*, Mei Wang^4*, Nikhil Grandhi, MD^3,5*, Theodore Thomas, MD^4*, Kristen M. Sanfilippo, MD^4,6, Graham Colditz, MD, DrPh^7*, Daphne R Friedman, MD^8,9,10, Martin William Schoen, MD, MPH^11* and Su-Hsin Chang, PhD^4,12*

¹Washington University St Louis, Saint Louis, MO
²City of Hope National Medical Center, Duarte, CA
³St. Louis Veterans Affairs Medical Center, St. Louis, MO
⁴St. Louis Veterans Affairs Medical Center Research Service, St. Louis, MO
⁵Washington University School of Medicine, Saint Louis, MO
⁶Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
⁷Washington University School of Medicine, Saint Louis
⁸Division of Medical Oncology, Duke University School of Medicine, Durham, NC
⁹Durham VA Medical Center, Durham, NC
¹⁰National Oncology Program, Department of Veterans Affairs, Washington, DC
¹¹Department of Veterans Affairs, St. Louis University, Saint Louis, MO
¹²Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO

Efstathios Kastritis, MD^1*, Giovanni Palladini, MD, PhD², Meletios A. Dimopoulos¹, Arnaud Jaccard^3*, Giampaolo Merlini, MD^2*, Foteini Theodorakakou, MD^1*, Despina Fotiou, MD, PhD^1*, Monique C Minnema^4*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath⁵, Elena Papachristou, MSc^6*, Giorgos Psarros^6*, Pieter Sonneveld, MD, PhD⁷ and Stefan Schonland^8*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
³Referral Center for AL Amyloidosis, Limoges, France
⁴Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁵Clinical Haematology, Cancer Division, University College London Hospital, London, United Kingdom
⁶Health Data Specialists, Dublin, Ireland
⁷Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁸University of Heidelberg, Heidelberg, Germany

Rajshekhar Chakraborty, MD¹, Divaya Bhutani, MD², Markus Mapara, MD³, Ran Reshef, MD, MSc⁴, Mathew S Maurer, MD, PhD^5*, Jai Radhakrishnan^6* and Suzanne Lentzsch, MD, PhD⁷

¹Columbia University Irving Medical Center, Thornwood, NY
²Columbia University, College of Physicians and Surgeons, New York, NY
³Columbia University College of Physicians and Surgeons, New York, NY
⁴Division of Hematology & Oncology, Columbia University Medical Center, New York
⁵Columbia, New York Presbyterian Hospital, New York, NY
⁶New York Presbyterian Hospital - Columbia Campus, New York, NY
⁷Division of Hematology & Oncology, Columbia University Medical Center, New York, NY

Lipi Chakravorty, MBBS^1*, Anthea Gibbons, MBBS^2*, Nirija Anderson^3*, Fiona Kwok, FRACP, FRCPA, MBBS^4*, Dariusz Korczyk, MBBS, FRACP^5*, Emad Uddin Abro, MBBS, BSc, FRACP, FRCPA^6*, Stephanie Lam, MB BS^7*, Simon Gibbs, FRACP, FRCPA, MBBS^8,9*, Peter Mollee, FRACP, MBBS, MSc, FRCPA^10,11 and M Hasib Sidiqi, MBBS, FRACP, FRCPA^12,13*

¹Haematology Department, Fiona Stanley Hospital, Perth, Australia
²Haematology Department, Princess Alexandra Hospital, Brisbane, Australia
³Princess Alexandra Hospital, Brisbane, QLD, Australia
⁴Westmead Hospital, Sydney, AUS
⁵Cardiology Department, Princess Alexandra Hospital, Woolloongabba, Australia
⁶Haematology Department, Princess Alexandra Hospital, Woolloongabba, Australia
⁷Fiona Stanley Hospital, Perth, Australia
⁸University of Melbourne, Greater Melbourne Area, AUS
⁹Eastern Health, Box Hill, Australia
¹⁰Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
¹¹Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
¹²Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia, Murdoch, Western Australia, AUS
¹³Curtin Medical School, Curtin University, Western Australia, Bentley, Western Australia, Australia

Cindy Varga, MD, BSc¹, Felix Eichinger^2*, Abhijit Naik^2*, Viji Nair^2*, Samih Nasr^3*, Agnes Fogo^4*, Denis Toskic, BS^5*, Matthias Kretzler^2* and Raymond Comenzo, MD^6,7

¹Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²University of Michigan, Ann Arbor
³Pathology, Mayo Clinic, Rochester
⁴Vanderbilt Univerisity, Nashville
⁵The John Davis Myeloma and Amyloid Program, Tufts Medical Center, Revere, MA
⁶Box 826, Tufts Medical Center, Boston, MA
⁷Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Mingqian Lin, MS¹, Aniko Szabo, PhD^2*, Liliana Pezzin^2*, Jing Dong, PhD^3*, Binod Dhakal, MD, MS^4*, Meera Mohan, MD⁵, Ravi Narra, MD^6*, Marcelo Pasquini, MD, MS³ and Anita D'Souza, MD, MS³

¹Medical College of Wisconsin, School of Medicine, MILWAUKEE, WI
²Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴BMT and Cellular Therapy, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee
⁵Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁶BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Eli Muchtar, MD¹, Vaishali Sanchorawala, MD², Hamza Hassan, MD^3*, Ute Hegenbart^4*, Stefan Schonland^5*, Hans Lee, MD⁶, Muzaffar H. Qazilbash, MD⁷, Andrew Kin, MD⁸, Christiane A. Houde, BS^9*, Francis Buadi, MD¹⁰, Angela Dispenzieri, MD¹¹, Eapen K. Jacob, MD¹², Sally Arai, MD¹³, Michelle Chin MD^14,15*, Rajshekhar Chakraborty, MD¹⁶, Suzanne Lentzsch, MD, PhD¹⁷, Hila Magen, MD^18*, Eden Shkury^19*, Caitlin Sarubbi, MD^20*, Heather Landau, MD²¹ and Morie A Gertz, MD^11*

¹Mayo Clinic, Rochester, Minnesota, Rochester, MN
²Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Section of Hematology and Oncology, Amyloidosis Center,, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA
⁴Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Neckargem??nd, Baden-W., Germany
⁵University of Heidelberg, Heidelberg, Germany
⁶Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Karmanos Cancer Institute/Wayne State University, DETROIT, MI
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹Mayo Clinic, Rochester, MN
¹²Mayo Clinic College of Medicine, Rochester, MN
¹³Stanford University Medical Center, Palo Alto, CA
¹⁴Stanford University School of Medicine, Stanford, CA, Stanford, CA
¹⁵University of Central Florida College of Medicine, Orlando, FL
¹⁶Columbia University Irving Medical Center, Thornwood, NY
¹⁷Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
¹⁸Tel-Hashomer, Chaim Sheba Medical Center, Ramat-Gan, Israel
¹⁹Sheba Medical Center, Ramat Gan, ISR
²⁰Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY
²¹Department of Medicine, Weill Cornell Medical College, New York, NY

Michael Rosenzweig¹, Yvonne Adeduni Efebera, MD, MPH², Efstathios Kastritis, MD^3*, Brandon Blue, MD⁴, Faizi Jamal^5*, Monique C Minnema^6*, Christopher Pericone^7*, Sandra Vasey^8*, Yuping Chen^9*, Sonja Kotoulek^8*, Bart Vandael^10*, Joana Duran^7*, Samer Khaled^11*, NamPhuong Tran^11*, Jessica Vermeulen^12* and Vaishali Sanchorawala, MD¹³

¹Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²Department of Hematology, Blood and Marrow Transplant, Ohio Health, Columbus, OH
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
⁶Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁷Janssen Research & Development, LLC, Raritan, NJ
⁸Janssen Research & Development, LLC, Spring House, PA
⁹Janssen Research & Development, LLC, Shanghai, China
¹⁰Janssen Research & Development, Beerse, Belgium
¹¹Janssen Research & Development, LLC, Los Angeles, CA
¹²Janssen Biologics BV, Leiden, Netherlands
¹³Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA